Yes I think they do interim analysis, which would be assessed by the DSMB overseeing the trial to ensure there were no safety concerns. For the company the data is still blinded though so the only comparison they have is overall response rates compared to the phase 2 trial. A previous update said that so far response rates were similar.
Yes I think they do interim analysis, which would be assessed by...
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
41.0¢ |
Change
0.005(1.23%) |
Mkt cap ! $504.7M | |||
| Open | High | Low | Value | Volume |
| 41.5¢ | 42.0¢ | 40.0¢ | $458.6K | 1.119M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 298731 | 41.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.5¢ | 49490 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| OPT (ASX) Chart |